Clinical evaluation of Deferasirox for removal of cadmium ions in rat

BioMetals

Volumn 23, Issue 4, 2010, Pages 707-712

  Saljooghi, Amir Shokooh ^a   Fatemi, S Jamil A ^a  

^a SHAHID BAHONAR UNIVERSITY OF KERMAN   (Iran)

Author keywords

Cadmium toxicity; Chelation therapy; Deferasirox; Rats

Indexed keywords

CADMIUM; DEFERASIROX; IRON;

ANEMIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CADMIUM POISONING; CLINICAL EVALUATION; CONTROLLED STUDY; DRUG STRUCTURE; FLUID INTAKE; FOOD COMPOSITION; FOOD INTAKE; HAIR LOSS; IRON BLOOD LEVEL; IRON CHELATION; MALE; NONHUMAN; RAT; TREATMENT DURATION; TREATMENT OUTCOME; WEANING;

ANIMALS; BENZOIC ACIDS; CADMIUM; CADMIUM POISONING; CHELATION THERAPY; HUMANS; IRON CHELATING AGENTS; MALE; MOLECULAR STRUCTURE; RATS; RATS, WISTAR; TRIAZOLES;

RATTUS; RATTUS NORVEGICUS;

EID: 79951973576     PISSN: 09660844     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10534-010-9337-x     Document Type: Article

References (26)

1. Akesson A, Lundh T, Vahter M, Bjellerup P, Lidfeldt J, Nerbrand C 2005 Tubular and glomerular kidney effects in Swedish women with low environmental cadmium exposure. Environ Health Persp 113:1627-1631
2. Cappellini MD 2008 Long-term efficacy and safety of deferasirox. Blood Rev 2:35-41
3. Fatemi SJ, Amiri A, Bazargan MH, Tubafard S, Fatemi SN 2007 Clinical evaluation of desferrioxamine (DFO) for removal of thallium ions in rat. Int J Artif Organs 30:902-905
4. Fatemi SJ, Tubafard S, Nadi B 2009 Evaluation of the effect of cadmium on rat organs and investigation of diethyl carbamate as an oral drug in treatment of cadmium toxicity. Med Chem Res 18:179-186
5. Franchini M, Gandini G, Gironcoli M 2000 Safety and efficiency of subcutaneous bolus injection of desferrioxamine in adult patients with iron overload. Blood 5:2776-2779
6. Hassler CS, Wilkinson KJ 2003 Failure of the biotic ligand and free-ion activity models to explain zinc bioaccumulation by Chlorella kesslerii. Toxicol Environ Chem 22:620-626
7. Heinz U, Hegetschweiler K, Acklin P, Faller B, Lattmann R, Schnebli HP (1999) 4-[3, 5-bis (2-hydroxyphenyl)-1, 2, 4-triazol-1-yl]-benzoic acid: a novel efficient and selective iron (III) complexing agent. Angew Chem Int Ed 38:2568-2570
8. Henkel G, Krebs B 2004 Metallothioneins: zinc, cadmium, mercury, and copper thiolates and selenolates mimicking protein active site features structural aspects and biological implications. Chem Rev 104:801-824
9. Huang HQ, Cao TM, Lin QM 2004 Characteristics of trapping copper iron with scrolled ferritin reactor in the flowing seawater. Environ Sci Tech 38:2476-2481
10. Ivanoviene L, Staneviciene I, Lesauskaite V, Sadauskiene I, Ivanov L 2004 Activities of tRNALeu and leucyl tRNA synthetase and programmed cell death in the liver of mice under experimental cadmium poisoning. J trace elem elect health dis 21:180-184
11. Lifton RP, Gharavi AG, Geller DS 2001 Molecular mechanisms of human hypertension. Cell 104:545-556
12. Lindsey WT, Olin BR 2007 New drug, deferasirox for transfusion-related iron overload: a clinical review. Clin Ther 29:2145-2166
13. Miao AJ, Wang WX, Juneau P 2005 Comparison of Cd, Cu, and Zn toxic effects on four marine phytoplankton by pulse-amplitude-modulated fluorometry. Environ Toxicol Chem 24:2603-2611 (Pubitemid 41445197)
14. Mirimanoff N, Wilkinson KJ 2000 Regulation of Zn accumulation by a freshwater gram-positive bacterium (Rhodococcus opacus). Environ Sci Tech 34:616-622
15. Nisbet-Brown E, Olivieri NF, Giardina PJ, Grady RW, Neufeld EJ, Sechaud R, Krebs-Brown AJ, Anderson JR, Alberti D, Sizer KC, Nathan DG 2003 Effectiveness and safety of ICL670 in iron-loaded patients with thalassemia: a randomised, double-blind, placebo-controlled, dose-escalation trial. Lancet 361:1597-1602
16. Satarug S, Nishijo M, Ujjin P, Vanavanitkun Y, Moore MR 2005 Cadmium-induced nephropathy in the development of high blood pressure. Toxicol Lett 157:57-68
17. Satarug S, Nishijo M, Lasker JM, Edwards RJ, Moore MR 2006 Kidney dysfunction and hypertension: role for cadmium, p450 and heme oxygenases? Tohoku J Exp Med 208:179-202
18. Scott LE, Orvig C 2009 Medicinal inorganic chemistry approaches to passivation and removal of aberrant metal ions in disease. Chem Rev 109:4885-4910
19. Shimoda R, Nagamine T, Takagi H, Mori M, Waalkes MP 2001 Induction of apoptosis in cells by cadmium quantitative negative correlation between basal or induced metallothionein concentration and apoptotic rate. Toxicol Sci 64:208-215
20. Shokooh Saljooghi A, Fatemi SJ 2010 Cadmium transport in blood serum. Toxicol Ind Health. doi:10.1177/07482337 10362375
21. Steinhauser S, Heinz U, Bartholomä M, Weyhermüller T, Nick H, Hegetschweiler K 2004 Complex formation of ICL670 and related ligands with Fe (III) and Fe (II). Eur J Inorg Chem 2004:4177-4192
22. Tubafard S, Fatemi SJ 2008 Chelation of bismuth by combining desferrioxamine and deferiprone in rats. Toxicol Ind Health 24:235-240
23. Tubafard S, Fatemi SJ, Shokooh Saljooghi A, Torkzadeh M 2010 Removal of vanadium by combining desferrioxamine and deferiprone chelators in rats. Med Chem Res. doi:10.1007/s00044-009-9235-3
24. Waisberg M, Joseph P, Hale B, Beyersmann D 2003 Molecular and cellular mechanisms of cadmium carcinogenesis. Toxicology 192:95-117
25. Wilde KL, Stauber JL, Markich SJ, Franklin NM, Brown PL 2006 The effect of pH on the uptake and toxicity of copper and zinc in a tropical freshwater alga (Chlorella sp.). Arch Environ Contamin Toxicol 51:174-185
26. Yang LPH, Keam SJ, Keating GM 2007 Deferasirox: a review of its use in the management of transfusional chronic iron overload. Drugs 67:2211-2230